Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 15 studies | 55% ± 17% | |
oligodendrocyte precursor cell | 15 studies | 57% ± 20% | |
astrocyte | 13 studies | 57% ± 19% | |
glutamatergic neuron | 12 studies | 47% ± 23% | |
GABAergic neuron | 9 studies | 47% ± 20% | |
neuron | 6 studies | 39% ± 16% | |
interneuron | 6 studies | 49% ± 15% | |
retinal ganglion cell | 6 studies | 36% ± 13% | |
endothelial cell | 4 studies | 33% ± 20% | |
granule cell | 4 studies | 47% ± 6% | |
fibroblast | 4 studies | 21% ± 3% | |
differentiation-committed oligodendrocyte precursor | 3 studies | 61% ± 13% | |
GABAergic interneuron | 3 studies | 43% ± 10% | |
GABAergic amacrine cell | 3 studies | 29% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 47% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 5556.43 | 2642 / 2642 | 98% | 41.25 | 693 / 705 |
lung | 81% | 809.56 | 468 / 578 | 45% | 4.35 | 523 / 1155 |
ovary | 70% | 623.52 | 126 / 180 | 16% | 0.34 | 68 / 430 |
pancreas | 0% | 0 | 0 / 328 | 76% | 8.88 | 136 / 178 |
spleen | 58% | 517.31 | 140 / 241 | 0% | 0 | 0 / 0 |
intestine | 6% | 41.01 | 60 / 966 | 39% | 1.74 | 206 / 527 |
eye | 0% | 0 | 0 / 0 | 41% | 1.54 | 33 / 80 |
thymus | 0% | 0.77 | 1 / 653 | 37% | 1.52 | 225 / 605 |
stomach | 0% | 0 | 0 / 359 | 36% | 1.64 | 103 / 286 |
kidney | 12% | 111.12 | 11 / 89 | 22% | 1.08 | 202 / 901 |
esophagus | 0% | 0 | 0 / 1445 | 33% | 1.64 | 60 / 183 |
uterus | 1% | 3.73 | 1 / 170 | 29% | 1.58 | 131 / 459 |
bladder | 0% | 0 | 0 / 21 | 28% | 1.75 | 140 / 504 |
skin | 5% | 34.77 | 90 / 1809 | 17% | 0.71 | 78 / 472 |
tonsil | 0% | 0 | 0 / 0 | 16% | 0.80 | 7 / 45 |
adrenal gland | 0% | 2.64 | 1 / 258 | 11% | 0.47 | 25 / 230 |
breast | 1% | 8.03 | 6 / 459 | 9% | 0.21 | 98 / 1118 |
heart | 8% | 53.79 | 71 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 3% | 0.26 | 12 / 406 |
adipose | 2% | 15.46 | 27 / 1204 | 0% | 0 | 0 / 0 |
prostate | 0% | 0 | 0 / 245 | 1% | 0.06 | 6 / 502 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0016363 | Cellular component | nuclear matrix |
GO_0005654 | Cellular component | nucleoplasm |
GO_0004864 | Molecular function | protein phosphatase inhibitor activity |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
Gene name | PHACTR3 |
Protein name | Phosphatase and actin regulator 3 (Scaffold-associated PP1-inhibiting protein) (Scapinin) Phosphatase and actin regulator 3 Phosphatase and actin regulator |
Synonyms | SCAPIN1 C20orf101 |
Description | |
Accessions | ENST00000395636.6 [Q96KR7-2] ENST00000355648.8 [Q96KR7-2] ENST00000434923.1 ENST00000361300.4 [Q96KR7-3] F6RP66 ENST00000371015.6 [Q96KR7-1] ENST00000492611.5 ENST00000359926.7 [Q96KR7-4] Q96KR7 ENST00000541461.5 [Q96KR7-2] A0A5F9ZHM5 |